Search | Page 22 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Impact of iron overload in myelodysplastic syndromes.

    ... Journal Title:  Blood Rev Primary Author:  ... (MDS), and most patients with MDS receive regular red blood cell transfusions, which can lead to iron overload . Some ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents

    ... Lenalidomide (LEN) has been shown to yield red blood cell (RBC) transfusion independence in about 25% of lower ...

    Research Article last updated 04/24/2012 - 2:47pm.

  3. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

    ... discuss methods for assessing PNH populations in both white blood cells and red blood cells and the relative advantages of measuring each. We present ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

    ... (AML). Most MDS patients eventually require transfusion of red blood cells for anaemia, placing them at risk of transfusional iron ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Therapy for aplastic anemia

    ... in the unrelated donor registry, including cord blood. He is red cell- and platelet transfusion -dependent. He has been recommended ...

    Research Article last updated 01/09/2012 - 10:58am.

  6. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.

    ... myelodysplastic syndromes (MDS) treated with red blood cell (RBC) transfusions. Transfusion dependency is associated with ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Iron chelation therapy in myelodysplastic syndromes.

    ... requires treatment. Supportive care measures such as red blood cell transfusions and erythroid colony stimulating factors are ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

    ... more and longer haematological responses and increased red blood cell transfusion independence . Azacitidine prolonged overall ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Andrew Dancis, MD

    ... to progress to leukemia. A characteristic finding in blood cell precursors of some individuals with myelodysplasia is the ringed ... with ringed sideroblasts.  Ringed sideroblasts are red blood cell precursors in the bone marrow that fail to develop normally ...

    Grant Recipient last updated 09/17/2015 - 9:07am.

  10. Medical Resources

    ... an expert to find an answer. Blood and Transplant Information Understanding your ... & cellular therapies worldwide. American Red Cross (800) 733-2767 Asians for Miracle Marrow ...

    Page last updated 08/20/2015 - 8:34am.